Microbicide Trials Network

The Mintaka Foundation for Medical Research in Geneva announced today that the Wellcome Trust, London, has awarded it approximately CHF 4,500,000 to meet the remaining costs of bringing its flagship product, an anti-HIV microbicide known as 5P12-RANTES, to a first safety trial in the clinic. Every year, there are millions of new infections from HIV. More than 95% of these occur in the developing ...

A local health resource center is reaching out to a group which is at high-risk for contracting HIV/AIDS.

The Mintaka Foundation for Medical Research in Geneva announced today that the Wellcome Trust, London, has awarded it approximately CHF 4,500,000 to meet the remaining costs of bringing its flagship product, an anti-HIV microbicide known as 5P12-RANTES, to a first safety trial in the clinic. Every year, there are millions of new infections from HIV...

Community AIDS Resource and Education Services has secured $217,204 in annual state funding for HIV prevention through 2012.

Remember the embarrassing non-response of Dick Cheney and John Edwards to Gwen Ifill's question about Black women with HIV/AIDS in the vice presidential debate in 2004?...

On the twentieth anniversary of the Medical Research Council's (MRC) research unit's presence in Uganda, Director Heiner Grosskurth looks back on the changing landscape of research into HIV/AIDS at the commemorative scientific symposium in Entebbe today. With Uganda often heralded as a model in Africa for fighting the disease, Professor Grosskurth reflects on how Uganda dramatically halved the ...

U.S. lawmakers on Wednesday introduced a congressional resolution condemning an anti-gay bill before Uganda's parliament, "calling it an attack on human rights and an obstacle to battling HIV/AIDS," Agence France-Presse reports...

The fund will be used to proceed an anti-HIV microbicide known as 5P12-RANTES, to clinical trials. 5P12-RANTES is a microbicides, developed with a purpose of preventing HIV from spreading. The clinical trial will be conducted to prove the safety of the microbicide.

On the twentieth anniversary of the Medical Research Council's (MRC) research unit's presence in Uganda, Director Heiner Grosskurth looks back on the changing landscape of research into HIV/AIDS at the commemorative scientific symposium in Entebbe today...

A team of scientists at The Scripps Research Institute has identified two compounds that act on novel binding sites for an enzyme used by the human immunodeficiency virus (HIV), the virus that causes AIDS...

A group of national organizations, in partnership with the Centers for Disease Control, plans and organizes National Black HIV/AIDS Awareness Day, held each Feb. 7. The day is intended to encourage black people across the U.S. to get educated, get tested.

Today, Merck is pleased to announce its $1.5 million funding commitment over three years to the BC Centre for Excellence in HIV/AIDS (BC-CfE) in support of its research program entitled "Seek and Treat for Optimal Prevention of HIV/AIDS", known as the "seek & treat" program, which will expand HIV treatment and care for hard-to-reach residents in Prince George and Vancouver's Downtown Eastside.

Over the past year, HIV testing centers report seeing a tremendous rise in HIV/AIDS in Abilene.

The Philippine National AIDS Council (PNAC) has noted a steady increase in the number of infections involving the human immunodeficiency virus (HIV) that causes the deadly AIDS, with at least one case reported every three days.

Did you know that, in Shelby County, 87 percent of men living with HIV/AIDS and 92 percent of women with the disease are African American? Yep, it's true. Those numbers come from the Memphis and Shelby County Health Department. As millions of Americans gnaw on hot wings and celery during SuperBowl XLIV (go Saints!) this Sunday, February 7th, they should take a moment to reflect on the AIDS ...

National Black HIV/AIDS Awareness Day is February 7, 2010 and Dallas County Health and Human Services will offer free sexually transmitted disease (STD) testing at multiple locations.

GENEVA--(Marketwire - February 4, 2010) - The Mintaka Foundation for Medical Research in Geneva announced today that the Wellcome Trust, London, has awarded it approximately CHF 4,500,000 to meet the remaining costs of bringing its flagship product, an anti-HIV microbicide known as 5P12-RANTES, to a first safety trial in the clinic.

GENEVA--(Marketwire - 02/04/10) - The Mintaka Foundation for Medical Research in Geneva announced today that the Wellcome Trust, London, has awarded it approximately CHF 4,500,000 to meet the remaining costs of bringing its flagship product, an anti-HIV microbicide known as 5P12-RANTES, to a first safety trial in the clinic. Every year, there are millions of new infections from HIV. More than 95 ...

Since January 1984, when the first HIV-AIDS case in the Philippines was reported, more than 4,000 HIV-positive cases have been recorded in the country.

The Philippine National AIDS Council (PNAC) has noted a steady increase in the number of infections involving the human immunodeficiency virus (HIV) that causes the deadly AIDS, with at least one case reported every three days.